 Neurotransmitter Agents
"Neurotransmitter Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.
| Descriptor ID |
D018377
|
| MeSH Number(s) |
D27.505.519.625 D27.505.696.577
|
| Concept/Terms |
Neurotransmitters- Neurotransmitters
- Transmitter Substances, Nerve
- Substances, Nerve Transmitter
- Nerve Transmitter Substances
- Neurotransmitter
|
Below are MeSH descriptors whose meaning is more general than "Neurotransmitter Agents".
Below are MeSH descriptors whose meaning is more specific than "Neurotransmitter Agents".
This graph shows the total number of publications written about "Neurotransmitter Agents" by people in UAMS Profiles by year, and whether "Neurotransmitter Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 2 | 2 | | 2021 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2013 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2010 | 1 | 0 | 1 | | 2009 | 0 | 2 | 2 | | 2008 | 1 | 1 | 2 | | 2006 | 0 | 3 | 3 | | 2005 | 3 | 0 | 3 | | 2003 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 1996 | 1 | 1 | 2 | | 1994 | 1 | 0 | 1 | | 1993 | 0 | 1 | 1 | | 1992 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 | | 1990 | 1 | 1 | 2 | | 1989 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neurotransmitter Agents" by people in Profiles over the past ten years.
-
Alqurashi MM, Al-Abbasi FA, Afzal M, Alghamdi AM, Zeyadi M, Sheikh RA, Alshehri S, Imam SS, Sayyed N, Kazmi I. Protective effect of sterubin against neurochemical and behavioral impairments in rotenone-induced Parkinson's disease. Braz J Med Biol Res. 2024; 57:e12829.
-
Mahdi WA, AlGhamdi SA, Alghamdi AM, Imam SS, Alshehri S, Almaniea MA, Hajjar BM, Al-Abbasi FA, Sayyed N, Kazmi I. Neuroprotectant Effects of Hibiscetin in 3-Nitropropionic Acid-Induced Huntington's Disease via Subsiding Oxidative Stress and Modulating Monoamine Neurotransmitters in Rats Brain. Molecules. 2023 Feb 01; 28(3).
-
Joffr? E, Xiao X, Correia MSP, Nookaew I, Sasse S, Globisch D, Zhu B, Sj?ling ?. Analysis of Growth Phases of Enterotoxigenic Escherichia coli Reveals a Distinct Transition Phase before Entry into Early Stationary Phase with Shifts in Tryptophan, Fucose, and Putrescine Metabolism and Degradation of Neurotransmitter Precursors. Microbiol Spectr. 2022 08 31; 10(4):e0175521.
-
Athavale ON, Cheng LK, Clark AR, Avci R, Du P. Mathematical Modeling of Gastric Slow Waves During Electrical Field Stimulation. Annu Int Conf IEEE Eng Med Biol Soc. 2022 07; 2022:2266-2269.
-
Fullerton MS, Colonne PM, Dragan AL, Brann KR, Kurten RC, Voth DE. Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells. mSphere. 2021 08 25; 6(4):e0044221.
-
Homberg JR, Kyzar EJ, Stewart AM, Nguyen M, Poudel MK, Echevarria DJ, Collier AD, Gaikwad S, Klimenko VM, Norton W, Pittman J, Nakamura S, Koshiba M, Yamanouchi H, Apryatin SA, Scattoni ML, Diamond DM, Ullmann JF, Parker MO, Brown RE, Song C, Kalueff AV. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies. Expert Opin Drug Discov. 2016; 11(1):11-25.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|